Non-invasive early cancer diagnosis within one hour report on the results system

AWSensors company with the European plan LIQBIOPSENS team developed a new type of liquid biopsy technique used for early diagnosis of colorectal cancer, the system can help quickly and easily conduct cancer diagnosis, and monitoring of cancer, compared to current diagnostic technology in terms of saving two-thirds of the costs.

In Spain AWSensors developed this highly sensitive molecular diagnostic system can be used to screen for cancer, which is based on liquid biopsy technique that resembles a small liquid sample of blood or saliva for analysis, enabling to complete the non-invasive diagnosis of cancer, and the technology can give the test results within an hour, when combined with the analysis of its genome is likely to obtain reliable diagnostic results, and provide help for the later development of accurate cancer chemotherapy .

This new diagnostic system will work with the Polytechnic University of Valencia developed quartz micro-sensor technology, the quartz micro-sensor technology can provide real-time analysis, a combination that can be reliably performed after DNA mutation. The new inspection system common in the next three years will be used to colorectal cancer patients blood samples for testing, and the current of colorectal cancer is the second leading cause of cancer deaths in Europe, but also, and breast, lung and prostate cancer in parallel cancer.

The current preferred method of reliable diagnosis of cancer is tumor tissue biopsy, but this method is invasive, but also very painful for the patient and expensive, and the technology is only a single aspect of the disease progression can provide information to patients; and article In this new system development, or at least three times cheaper than the cost of the current real-time monitoring methods, such as real-time quantitative PCR technology. The researchers plan to carry out this LiqBiopSens aims to develop simple, inexpensive and without early diagnosis and monitoring of invasive cancer.

By detecting mutations associated with cancer tumor tissue to release the body of DNA, the new technique can reliably existence and evolution of cancer diagnosis and avoid false positive results. Currently AWSensors has begun trying to make use of the crystal sensor so that it can work efficiently, and better detect molecular differences between different liquids biopsies and materials.